BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $359,378 | -14.1% | 9,522 | +3.8% | 0.01% | 0.0% |
| Q2 2023 | $418,423 | +11.5% | 9,173 | +34.7% | 0.01% | 0.0% |
| Q1 2023 | $375,258 | -13.3% | 6,809 | -19.8% | 0.01% | -25.0% |
| Q4 2022 | $432,888 | -27.7% | 8,493 | -9.0% | 0.01% | -38.5% |
| Q2 2022 | $599,000 | -22.2% | 9,333 | -6.0% | 0.01% | -23.5% |
| Q1 2022 | $770,000 | -4.6% | 9,932 | +5.6% | 0.02% | -10.5% |
| Q4 2021 | $807,000 | +4.4% | 9,401 | -2.2% | 0.02% | -9.5% |
| Q3 2021 | $773,000 | -1.5% | 9,611 | -1.4% | 0.02% | -4.5% |
| Q2 2021 | $785,000 | -3.0% | 9,749 | +1.7% | 0.02% | -15.4% |
| Q1 2021 | $809,000 | +22.4% | 9,587 | +16.4% | 0.03% | +13.0% |
| Q4 2020 | $661,000 | +35.2% | 8,236 | +35.5% | 0.02% | +9.5% |
| Q3 2020 | $489,000 | -6.9% | 6,078 | – | 0.02% | -4.5% |
| Q2 2020 | $525,000 | +6.1% | 0 | -100.0% | 0.02% | -8.3% |
| Q1 2020 | $495,000 | +1.0% | 6,098 | +4.2% | 0.02% | +20.0% |
| Q4 2019 | $490,000 | -5.8% | 5,855 | -1.6% | 0.02% | -23.1% |
| Q3 2019 | $520,000 | +11.8% | 5,948 | +4.0% | 0.03% | -42.2% |
| Q1 2019 | $465,000 | +17.1% | 5,719 | -5.2% | 0.04% | +45.2% |
| Q4 2018 | $397,000 | -19.1% | 6,033 | -5.2% | 0.03% | -18.4% |
| Q3 2018 | $491,000 | +13.1% | 6,367 | +8.3% | 0.04% | -7.3% |
| Q2 2018 | $434,000 | +14.5% | 5,878 | +0.9% | 0.04% | +10.8% |
| Q1 2018 | $379,000 | +14.2% | 5,823 | +10.1% | 0.04% | -2.6% |
| Q3 2017 | $332,000 | +1.8% | 5,287 | -1.7% | 0.04% | -5.0% |
| Q2 2017 | $326,000 | +21.6% | 5,379 | +4.0% | 0.04% | +8.1% |
| Q1 2017 | $268,000 | +2.7% | 5,174 | -12.2% | 0.04% | -2.6% |
| Q4 2016 | $261,000 | -6.8% | 5,890 | 0.0% | 0.04% | -13.6% |
| Q3 2016 | $280,000 | +5.3% | 5,890 | 0.0% | 0.04% | +4.8% |
| Q2 2016 | $266,000 | +9.9% | 5,890 | +0.0% | 0.04% | +13.5% |
| Q1 2016 | $242,000 | -99.9% | 5,888 | +13.5% | 0.04% | -45.6% |
| Q2 2015 | $362,727,000 | +3.3% | 5,187 | +1.2% | 0.07% | +3.0% |
| Q1 2015 | $351,200,000 | +86616.0% | 5,127 | -7.2% | 0.07% | -1.5% |
| Q4 2014 | $405,000 | +2.0% | 5,527 | 0.0% | 0.07% | +4.7% |
| Q3 2014 | $397,000 | -3.6% | 5,527 | -3.1% | 0.06% | -33.3% |
| Q2 2014 | $412,000 | +1.2% | 5,701 | +3.1% | 0.10% | -13.5% |
| Q1 2014 | $407,000 | +6.0% | 5,527 | 0.0% | 0.11% | +11.0% |
| Q4 2013 | $384,000 | +5.8% | 5,527 | 0.0% | 0.10% | -12.3% |
| Q3 2013 | $363,000 | -5.2% | 5,527 | 0.0% | 0.11% | -17.4% |
| Q2 2013 | $383,000 | – | 5,527 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |